Abbott (NYSE:ABT) announced today that it is introducing the Libre Sense glucose sport biosensor for measuring athletes’ glucose. The company touts the Libre Sense as the world’s first glucose sport biosensor, using Abbott’s FreeStyle Libre continuous glucose monitor (CGM) technology to become the first personal-use product that allows for use beyond diabetes, according to a news […]
Moody’s sees higher earnings, increased demand for medical device companies
Moody’s Investors Service announced today that it is changing its outlook for the medical device industry to positive — up from stable. The COVID-19 pandemic previously caused a suspension of non-urgent medical care, but procedure numbers have bounced back, said Moody’s, which expects the positive trend to continue as a result of pent-up demand and […]
Everything you need to know about medical device creation
Medtech development is hard. Medical device creation can require manufacturing know-how in areas as wide-ranging as electrical components, high-performance polymers, molding and machining – and that doesn’t even include the required expertise in design, regulatory requirements and achieving reimbursement. The good news is that the companies serving the medical device industry have become specialized experts. […]
MedTech 100 roundup: Stocks top pre-pandemic high
After weeks of flirting with the heights hit before COVID-19 ravaged the markets, medtech stocks finally topped the pre-pandemic high last week. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — spiked up to 93.11 points on Sep. 2, nearly a full point ahead of the pre-pandemic high of […]
The top 5 MassDevice stories of the week — September 4, 2020
Medtronic (NYSE:MDT) and a major development involving medtech reimbursement dominated medical device industry news over the past week. As the week closes out, there’s also a trending story on MassDevice that includes good news: Abbott (NYSE:ABT) is reportedly hiring 2,000 new employees in Illinois to increase manufacturing for its rapid COVID-19 test. Want to hear more about […]
Report: Abbott to hire 2,000 in Illinois to make rapid COVID-19 test
Abbott (NYSE:ABT) is reportedly set to hire 2,000 new employees to increase manufacturing for its rapid COVID-19 test. The Chicago Sun-Times reported last week that the Abbot Park, Ill.-based company would be adding jobs at its Gurnee, Ill., facility following the FDA emergency use authorization (EUA) for its BinaxNow COVID-19 Ag Card and the subsequent announcement […]
Report: Feds to send Abbott’s rapid tests to states for school reopenings
The U.S. government is reportedly set to use rapid COVID-19 tests it purchased from Abbott (NYSE:ABT) for school reopenings. Reuters reported that the feds will send an “overwhelming majority” of Abbott’s tests to governors and state territories to support school reopenings and other critical tasks, according to a Trump administration official. The administration struck a $750 […]
Abbott launches trial for drug-eluting resorbable scaffold
Abbott (NYSE:ABT) announced today that it started the LIFE-BTK clinical trial for its Espirit BTK everolimus-eluting resorbable scaffold system. According to a news release, Abbott’s Espirit system is the first to begin an investigational device exemption (IDE) trial in the U.S. for a fully resorbable device for treating below-the-knee blocked arteries or critical limb ischemia (CLI) […]
Roche to compete against Abbott with fast COVID-19 antigen tests
Roche (SWX: RO, ROG) plans to launch a SARS-CoV-2 rapid antigen test that doesn’t need lab equipment to process results — similar to the test that Abbott (NYSE:ABT) recently launched. Roche’s test will launch late this month in Europe, initially making 40 million tests available per month. The Swiss pharma and diagnostics giant plans to also […]
Abbott wins Medicare reimbursement for FreeStyle Libre 2
Abbott (NYSE:ABT) announced today that its next-generation FreeStyle Libre 2 iCGM is now available to Medicare patients. The integrated continuous glucose monitoring (iCGM) system met the codes for therapeutic CGM systems used for coverage by the U.S. Centers for Medicare & Medicaid Services (CMS), making it accessible to all Medicare patients with diabetes who meet the […]
MedTech 100 roundup: Industry reaches new heights again
The past month has seen a resurgence from medtech companies in the markets and last week saw the best performance yet. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 90.78 points at the end of last week (Aug. 28). Overall, medtech stocks saw a 1.3% increase […]
- 1
- 2
- 3
- …
- 78
- Next Page »
